Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Morotti

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Nature Immunology|October 30, 2020
Author Correction: A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
Cancer Cell|February 13, 2020
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial CellsZhiyuan Hu, Mara Artibani, Abdulkhaliq Alsaadi, et al.
Nature|April 24, 2024
PGE<sub>2</sub> limits effector expansion of tumour-infiltrating stem-like CD8<sup>+</sup> T cellsSebastian B Lacher, Janina Dörr, Gustavo P de Almeida, et al.
Cell Reports|July 21, 2021
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STINGMarine Bruand, David Barras, Marco Mina, et al.
JCI Insight|May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cellsMara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
Nature|April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial functionMatteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Cancer Cell|August 1, 2025
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancerEleonora Ghisoni, Fabrizio Benedetti, Aspram Minasyan, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Nature Immunology|October 30, 2020
Author Correction: A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signalsPhilippos Demetriou, Enas Abu-Shah, Salvatore Valvo, et al.
British Journal of Cancer|March 30, 2021
Promises and challenges of adoptive T-cell therapies for solid tumoursMatteo Morotti, Ashwag Albukhari, Abdulkhaliq Alsaadi, et al.
Cancer Cell|February 13, 2020
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial CellsZhiyuan Hu, Mara Artibani, Abdulkhaliq Alsaadi, et al.
Nature|April 24, 2024
PGE<sub>2</sub> limits effector expansion of tumour-infiltrating stem-like CD8<sup>+</sup> T cellsSebastian B Lacher, Janina Dörr, Gustavo P de Almeida, et al.
Cell Reports|July 21, 2021
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STINGMarine Bruand, David Barras, Marco Mina, et al.
JCI Insight|May 4, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cellsMara Artibani, Kenta Masuda, Zhiyuan Hu, et al.
Nature|April 24, 2024
PGE<sub>2</sub> inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial functionMatteo Morotti, Alizee J Grimm, Helen Carrasco Hope, et al.
Science Immunology|February 2, 2024
Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8<sup>+</sup> T-myeloid cell networks in melanomaDavid Barras, Eleonora Ghisoni, Johanna Chiffelle, et al.
Cancer Cell|August 1, 2025
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancerEleonora Ghisoni, Fabrizio Benedetti, Aspram Minasyan, et al.
Pageof 6